产品标题 产品货号 产品规格 厂家
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5597445 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5597995 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5598035 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5601095 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5603555 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5603795 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5602995 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5604615 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5604585 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5605575 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5605385 ugORIGENE TECHNOLOGIES
Phospholipase A2, group X (PLA2G10) from ORIGENE TECHNOLOGIESLY418602100 ugORIGENE TECHNOLOGIES
Human RNA: Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCR5605865 ugORIGENE TECHNOLOGIES
Phospholipase A2, group XVI (PLA2G16), transcript variant 2 from ORIGENE TECHNOLOGIESLY426918100 ugORIGENE TECHNOLOGIES
Phospholipase A2, group XVI (PLA2G16), transcript variant 1 from ORIGENE TECHNOLOGIESLY416202100 ugORIGENE TECHNOLOGIES
Phospholipase A1 member A (PLA1A) from ORIGENE TECHNOLOGIESLY414332100 ugORIGENE TECHNOLOGIES
Phospholipase A2 receptor 1, 180kDa (PLA2R1), transcript variant 2 from ORIGENE TECHNOLOGIESLY423477100 ugORIGENE TECHNOLOGIES
Phospholipase B domain containing 1 (PLBD1) from ORIGENE TECHNOLOGIESLY410947100 ugORIGENE TECHNOLOGIES
Phospholipase B domain containing 2 (PLBD2), transcript variant 2 from ORIGENE TECHNOLOGIESLY431479100 ugORIGENE TECHNOLOGIES
Phospholipase A2, group XV (PLA2G15) from ORIGENE TECHNOLOGIESLY415835100 ugORIGENE TECHNOLOGIES
Phospholipase B1 (PLB1), transcript variant 1 from ORIGENE TECHNOLOGIESLY407199100 ugORIGENE TECHNOLOGIES
Phospholipase C, beta 1 (phosphoinositide-specific) (PLCB1), transcript variant 1 from ORIGENE TECHNOLOGIESLY414715100 ugORIGENE TECHNOLOGIES
Phospholipase C, beta 1 (phosphoinositide-specific) (PLCB1), transcript variant 2 from ORIGENE TECHNOLOGIESLY430611100 ugORIGENE TECHNOLOGIES
Phospholipase C, beta 2 (PLCB2) from ORIGENE TECHNOLOGIESLY417886100 ugORIGENE TECHNOLOGIES
Phospholipase C, beta 4 (PLCB4), transcript variant 2 from ORIGENE TECHNOLOGIESLY405361100 ugORIGENE TECHNOLOGIES
Phospholipase C, beta 4 (PLCB4), transcript variant 3 from ORIGENE TECHNOLOGIESLY433670100 ugORIGENE TECHNOLOGIES
Phospholipase C, delta 3 (PLCD3) from ORIGENE TECHNOLOGIESLY408836100 ugORIGENE TECHNOLOGIES
Phospholipase C, delta 4 (PLCD4) from ORIGENE TECHNOLOGIESLY409963100 ugORIGENE TECHNOLOGIES
Phospholipase C, delta 1 (PLCD1), transcript variant 2 from ORIGENE TECHNOLOGIESLY416791100 ugORIGENE TECHNOLOGIES
Phospholipase C, epsilon 1 (PLCE1), transcript variant 1 from ORIGENE TECHNOLOGIESLY414037100 ugORIGENE TECHNOLOGIES
Phospholipase C, beta 1 (phosphoinositide-specific) (PLCB1), transcript variant 2 from ORIGENE TECHNOLOGIESLY405340100 ugORIGENE TECHNOLOGIES
Phospholipase C, eta 1 (PLCH1), transcript variant 1 from ORIGENE TECHNOLOGIESLY427323100 ugORIGENE TECHNOLOGIES
Phospholipase C, gamma 1 (PLCG1), transcript variant 1 from ORIGENE TECHNOLOGIESLY419181100 ugORIGENE TECHNOLOGIES
Phospholipase C, gamma 1 (PLCG1), transcript variant 2 from ORIGENE TECHNOLOGIESLY405368100 ugORIGENE TECHNOLOGIES
Phospholipase C, gamma 2 (phosphatidylinositol-specific) (PLCG2) from ORIGENE TECHNOLOGIESLY419182100 ugORIGENE TECHNOLOGIES
Phospholipase C, eta 2 (PLCH2) from ORIGENE TECHNOLOGIESLY415143100 ugORIGENE TECHNOLOGIES
Phospholipase C-like 1 (PLCL1) from ORIGENE TECHNOLOGIESLY432418100 ugORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5022865x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5022885x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5022905x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5022875x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5022895x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5030405x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5042595x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5042585x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5042605x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5030435x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5177745x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS5177735x5umORIGENE TECHNOLOGIES
Human Lung; Pneumonia, organizing from ORIGENE TECHNOLOGIESCS6018165x5umORIGENE TECHNOLOGIES
 |< < 1234 1235 1236 1237 1238 1239 1240 1241 1242 > >| 第 1239/6274 页